Parallel Advisors’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.66K | Buy |
131
+10
| +8% | +$432 | ﹤0.01% | 2669 |
|
|
2025
Q1 | $4.18K | Sell |
121
-3
| -2% | -$104 | ﹤0.01% | 2725 |
|
|
2024
Q4 | $3.4K | Sell |
124
-317
| -72% | -$8.7K | ﹤0.01% | 2764 |
|
|
2024
Q3 | $11.2K | Buy |
441
+405
| +1,125% | +$10.3K | ﹤0.01% | 2338 |
|
|
2024
Q2 | $912 | Buy |
+36
| New | +$912 | ﹤0.01% | 2969 |
|
|
2023
Q4 | – | Sell |
-28
| Closed | -$738 | – | 3319 |
|
|
2023
Q3 | $738 | Hold |
28
| – | – | ﹤0.01% | 3029 |
|
|
2023
Q2 | $482 | Hold |
28
| – | – | ﹤0.01% | 3108 |
|
|
2023
Q1 | $464 | Hold |
28
| – | – | ﹤0.01% | 3139 |
|
|
2022
Q4 | $213 | Buy |
+28
| New | +$213 | ﹤0.01% | 3178 |
|
|
2022
Q3 | – | Sell |
-34
| Closed | – | – | 3119 |
|
|
2022
Q2 | $0 | Buy |
+34
| New | – | ﹤0.01% | 2981 |
|
|
2022
Q1 | – | Sell |
-121
| Closed | -$2K | – | 2960 |
|
|
2021
Q4 | $2K | Sell |
121
-367
| -75% | -$6.07K | ﹤0.01% | 2651 |
|
|
2021
Q3 | $23K | Hold |
488
| – | – | ﹤0.01% | 1633 |
|
|
2021
Q2 | $30K | Sell |
488
-545
| -53% | -$33.5K | ﹤0.01% | 1451 |
|
|
2021
Q1 | $64K | Buy |
+1,033
| New | +$64K | ﹤0.01% | 1055 |
|